State of the Science for Neurorecovery/Neuroprotection as well as Visual Restoration Products for Retinal Degenerative Conditions
Past Event Date:
Speaker:Ron Schuchard, PhD, FARVO ERI Executive Director Envision, Inc.
Meeting room:Room 204 - Main Conference Room
Abstract - Recent FDA cleared/approved devices and biologics as well as current clinical trials in these types of products which promised improved vision by neurorecovery or at least slowing of the vision loss progression with neuroprotection including: 1) Spark Therapeutics LUXTURNA gene therapy; and 2) Okuvision OkuStim Electrical Stimulation Therapy. In addition, retinal and cortical prosthetics have promised restored vision by substituting mechanisms in the visual system. This presentation will provide a review of the actual results of these types of products and the challenges that would need to be overcome for these products to provide the promised improvement in vision.